| Role |
Name |
Disclosure |
Details |
| Author | Michael Grasso, MD, Chairman, Department of Urology, Saint Vincent's Medical Center; Professor and Vice Chairman, Department of Urology, New York Medical College | Nothing to disclose | Details | | Coauthor | Andrew Ira Fishman, MD, Staff Physician, Department of Urology, Saint Vincent Catholic Medical Center | Nothing to disclose | Details | | Coauthor | Keith T Tracy, MD, Staff Physician, Department of Urology, New York Medical College, Westchester Medical Center | Nothing to disclose | Details | | Medical Editor | Erik T Goluboff, MD, Assistant Professor, Program Director, Department of Urology, Columbia-Presbyterian Medical Center, Columbia University | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | CME Editor | J Stuart Wolf, Jr, MD, FACS, David A Bloom Professor of Urology, Director, Division of Minimally Invasive Urology, Department of Urology, University of Michigan Medical Center | Terumo Corporation Omeros Corporation | Details | | Chief Editor | Stephen W Leslie, MD, FACS, Founder and Medical Director, Lorain Kidney Stone Research Center; Clinical Assistant Professor, Department of Urology, University of Toledo | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Michael Grasso, Author |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Keith T Tracy, Coauthor |
The contributor discloses no conflict of interest. |
|